Business Context and Reporting Period
This Form 6-K filing by Novo Nordisk A/S is dated August 6, 2026. The report discloses transactions in Novo Nordisk shares by board members, executives, and associated persons in accordance with Article 19 of Regulation No. 596/2014 on market abuse. The company is a leading global healthcare firm headquartered in Denmark, employing approximately 66,700 people across 80 countries.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. It strictly reports on insider share transactions.
| Transaction Type | Instrument | Price (DKK) | Volume (Shares) | Total Value (DKK) |
|---|---|---|---|---|
| Vesting of Restricted Shares (100th Anniversary) | Novo Nordisk B Shares | 294.30 | 74 | 21,778.20 |
Note: The table above reflects the identical transaction details reported for each individual listed in the filing.
Material Changes
The filing does not report material changes to the company's financial position or operations. It documents a routine vesting event for the "Novo Nordisk 100th Anniversary Shares" program. All reported transactions occurred on August 5, 2026, outside a trading venue.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The document serves solely as a regulatory notification of insider trading activity.
Important Facts for Investors
- Transaction Nature: All reported transactions were vestings of restricted shares under the "Novo Nordisk 100th Anniversary Shares" program, not open market sales or purchases.
- Participants: The filing covers 11 individuals, including CEO Maziar Mike Doustdar, CFO Karsten Munk Knudsen, CSO Martin Holst Lange, and several Board members (e.g., Désirée Jantzen Asgreen, Elisabeth Dahl Christensen).
- Uniformity: Every individual reported the exact same transaction: 74 shares at DKK 294.30 per share, totaling DKK 21,778.20.
- Market Impact: These transactions occurred outside a trading venue and represent a negligible volume relative to the company's total market capitalization.